Ultragenyx Pharmaceutical (RARE) Cash & Equivalents (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) posted Cash & Equivalents of $125 million for Q2 2026, down 29.0% from $176 million a year earlier and down 28.6% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical's Cash & Equivalents came in at $421 million, up 142.0% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -10.0% (FY2020 to FY2025).
- In prior years, Ultragenyx Pharmaceutical's Cash & Equivalents was $174 million in FY2024 (-18.7%), $214 million in FY2023 (+61.0%), $132.94 million in FY2022 (-56.8%) and $307.58 million in FY2021 (-56.9%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents since Q1 2024.
- On a year-over-year basis, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 28.0%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q2 2024, with growth of 371.0%; the weakest was Q3 2023, with a decline of 81.5%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $175 million (Q1 2026), $421 million (Q4 2025) and $202.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Ultragenyx Pharmaceutical | 1.50 Bn | -302.56 Mn | 180.00 Mn | 125.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.00 Mn |
| Mar 31, 2026 | 175.00 Mn |
| Dec 31, 2025 | 421.00 Mn |
| Sep 30, 2025 | 202.51 Mn |
| Jun 30, 2025 | 176.00 Mn |
| Mar 31, 2025 | 127.00 Mn |
| Dec 31, 2024 | 174.00 Mn |
| Sep 30, 2024 | 150.62 Mn |
| Jun 30, 2024 | 480.69 Mn |
| Mar 31, 2024 | 112.25 Mn |
| Dec 31, 2023 | 214.00 Mn |
| Sep 30, 2023 | 72.58 Mn |
| Jun 30, 2023 | 102.06 Mn |
| Mar 31, 2023 | 85.77 Mn |
| Dec 31, 2022 | 132.94 Mn |
| Sep 30, 2022 | 391.65 Mn |
| Jun 30, 2022 | 159.87 Mn |
| Mar 31, 2022 | 153.99 Mn |
| Dec 31, 2021 | 307.58 Mn |
| Sep 30, 2021 | 197.54 Mn |
API Access
Ultragenyx Pharmaceutical Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();